These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30519574)

  • 1. Clinical Course of Dual-Chamber Implantable Cardioverter-Defibrillator Recipients followed by Cardiac Remote Monitoring: Insights from the LION Registry.
    Schwab JO; Nägele H; Oswald H; Klein G; Gunkel O; Lang A; Bauer WR; Korb P; Hauser T
    Biomed Res Int; 2018; 2018():3120480. PubMed ID: 30519574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter, prospective, randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs.
    Sweeney MO; Ellenbogen KA; Casavant D; Betzold R; Sheldon T; Tang F; Mueller M; Lingle J;
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):811-7. PubMed ID: 16101620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of the atrial channel for ventricular arrhythmia therapy in the dual chamber implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1309-19. PubMed ID: 11196552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring.
    Galand V; Hwang E; Gandjbakhch E; Sebag F; Marijon E; Boveda S; Leclercq C; Defaye P; Rosier A; Martins RP
    Arch Cardiovasc Dis; 2021 May; 114(5):407-414. PubMed ID: 34088625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of dual chamber pacing on the incidence of atrial and ventricular tachyarrhythmias in recipients of implantable cardioverter defibrillators.
    Strohmer B; Mermi J; Castellanos E; Mayr H; Gill J; Abadia AA; Kuehl M; Wolpert C
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S249-54. PubMed ID: 15683508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of arrhythmic events is useful to detect lead failure earlier in patients followed by remote monitoring.
    Nishii N; Miyoshi A; Kubo M; Miyamoto M; Morimoto Y; Kawada S; Nakagawa K; Watanabe A; Nakamura K; Morita H; Ito H
    J Cardiovasc Electrophysiol; 2018 Mar; 29(3):463-470. PubMed ID: 29194831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of antitachycardia pacing alerts for the reduction of emergency presentations following shocks in patients with implantable cardioverter-defibrillators: implications for the implementation of remote monitoring.
    Boulé S; Ninni S; Finat L; Botcherby EJ; Kouakam C; Klug D; Marquié C; Brigadeau F; Lacroix D; Kacet S; Guédon-Moreau L
    Europace; 2016 Dec; 18(12):1809-1817. PubMed ID: 26711741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dual-chamber implantable automatic defibrillators. Experiences apropos of 16 cases].
    Le Franc P; Klug D; Lacroix D; Kouakam C; Jarwé M; Kacet S
    Arch Mal Coeur Vaiss; 1998 Jun; 91(6):739-44. PubMed ID: 9749190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial Rate-Responsive Pacing and Incidence of Sustained Atrial Arrhythmias in Patients with Implantable Cardioverter Defibrillators.
    Fontenla A; Salguero R; Martinez-Ferrer JB; Rodriguez A; Alzueta J; Garcia E; Basterra N; Romero R; Concha JF; Viñolas X; Villacastin J; Lopez-Gil M; Arribas F
    Pacing Clin Electrophysiol; 2016 Jun; 39(6):548-56. PubMed ID: 27001125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interruption of Pacing Following Nonsustained Ventricular Tachycardia in an AAI Programmed Implantable Cardioverter Defibrillator.
    Egan P; Wilkoff BL; Tchou P
    Pacing Clin Electrophysiol; 2015 Sep; 38(9):1082-90. PubMed ID: 26010870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradevice interaction in a dual chamber implantable cardioverter defibrillator preventing ventricular tachyarrhythmia detection.
    Shivkumar K; Feliciano Z; Boyle NG; Wiener I
    J Cardiovasc Electrophysiol; 2000 Nov; 11(11):1285-8. PubMed ID: 11083251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporadic high pacing and shock impedance on remote monitoring in hybrid implantable cardioverter-defibrillator systems: Clinical impact and management.
    Pignalberi C; Mariani MV; Castro A; Piro A; Magris B; Albano B; Aquilani S; Magnocavallo M; Colivicchi F; Fedele F; Lavalle C
    Heart Rhythm; 2021 Aug; 18(8):1292-1300. PubMed ID: 33838316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator.
    Heidbüchel H; Lioen P; Foulon S; Huybrechts W; Ector J; Willems R; Ector H
    Europace; 2008 Mar; 10(3):351-7. PubMed ID: 18245771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should all implantable cardioverter defibrillators for ventricular arrhythmias be dual-chamber devices?
    Lee KL; Lau CP
    Curr Cardiol Rep; 2001 Nov; 3(6):447-50. PubMed ID: 11602074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Merits and limitations of the mode switching rate stabilization pacing algorithms in the implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Interv Card Electrophysiol; 2001 Sep; 5(3):309-18. PubMed ID: 11500586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
    Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
    JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reverse mode switch algorithm: how well does it work?
    Akerström F; Arias MA; Pachón M; Puchol A; Jiménez-López J; Rodríguez-Padial L
    Heart Rhythm; 2013 Aug; 10(8):1146-52. PubMed ID: 23732226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.